vimarsana.com
Home
Live Updates
Exponent : FDA Commits to DHTs for Clinical Drug Development
Exponent : FDA Commits to DHTs for Clinical Drug Development
Exponent : FDA Commits to DHTs for Clinical Drug Development
Plan to include framework, oversight, and external input on policy governing the use of digital health technologies for modernizing clinical trials
The Food and Drug... | April 28, 2023
Related Keywords
,
Product Development ,
Office Of Clinical ,
Radiological Health ,
Drug Administration ,
Digital Health Center ,
Oncology Center ,
Biological Product Development ,
Prescription Drug User Fee Act ,
Drug Evaluation ,
Biologics Evaluation ,
Clinical Policy ,
Drug Omnibus Reform Act ,
Exponent ,
Nc Stock Exchange ,
News ,
Information ,
Press Release ,
Plan ,
O ,
Nclude ,
End ,
Xternal ,
Input ,
N ,
Policy ,
Governing ,
The ,
Tse ,
F ,
Digital ,
Health ,
Technologies ,
Or ,
Modernizing ,
Linical ,
Wood ,
Nd Expo Us30214u1025 ,